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A B S T R A C T
Background: HIV and psychiatric disorders are closely correlated and are accompanied by some similar risk
factors.
Objective: The aim of this study was to assess psychiatric comorbidity and health service utilization for mental
problems among people living with HIV/AIDS in Iran.
Methods: A total of 250 cases were randomly selected from a large referral center for HIV treatment and care in
Tehran, Iran. Psychiatric disorders in the past 12months including mood, anxiety, and substance use disorders
were assessed through face-to-face interview, using a validated Persian translation of the Composite
International Diagnostic Interview (CIDI v2.1). Severity of psychiatric disorders, social support, socio-economic
status, service utilization and HIV-related indicators were assessed.
Results: Participants consisted of 147 men and 103 women. Psychiatric disorders were found in 50.2% (95%
conﬁdence interval: 43.8–56.6) of the participants. Major depressive disorder was the most prevalent diagnosis
(32.1%), followed by substance use disorders (17.1%). In bivariate analysis, psychiatric disorders were sig-
niﬁcantly higher among male gender, single and unemployed individuals and those with lower social support. In
multivariate regression analysis, only social support was independently associated with psychiatric disorders.
Among those with a psychiatric diagnosis, 41.1% had used a health service for mental problems and 53% had
received minimally adequate treatment.
Conclusion: The ﬁndings of the study highlight the importance of mental health services in the treatment of
people living with HIV/AIDS.
1. Introduction
There are 36.7 million people living with HIV/AIDS (PLWHA) in the
world [1]. Although the annual incidence of HIV infection is decreasing
globally, HIV prevalence is rising due to development of more eﬀective
treatment and higher survival [2]. Therefore, the health system is now
facing emerging challenges of non-communicable diseases and mental
health problems among PLWHA [3].
In Iran, there are about 35 thousand registered cases of HIV infec-
tion, identiﬁed through health care and surveillance systems [4]. In
Iran, HIV prevalence in general population is 0.15% [5]. However, the
country suﬀers from concentrated HIV epidemics among injecting and
non-injecting drug users [6,7]. While the global burden of HIV/AIDS
has been declining in the last decade [8], it is projected that the burden
will continue to grow during the next 10 years in Iran [9]. HIV treat-
ment and care is widely available in Iran [5], there are more than a
thousand Voluntary Counseling and Testing (VCT) centers and 162
health facilities that provide anti-retroviral therapy (ART). In 2014,
among those eligible for receiving ART, 20.1% were receiving it [5].
Psychosocial services for PLWHA and their families are provided
through 48 “Positive Clubs” across the country [5].
HIV, psychiatric disorders and substance use disorders are closely
correlated and are accompanied by similar risk factors. They also share
common consequences such as stigma and discrimination [10]. Mental
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illnesses and substance use disorders can act as risk factors for HIV
acquisition [11–14]. Globally, injecting drug use is a major route of HIV
transmission [1]. It accounts for 66% of the HIV cases in Iran [4]. Im-
paired judgment, diminished inhibition and engagement in high risk
sexual behaviors, lack of insight, and poor self-care and neglecting
physical health have been proposed as the underlying mechanisms
[15].
On the other hand, HIV infection can serve as a risk factor towards
development of psychiatric disorders [16,17]. Stressor of sero-conver-
sion, chronic adjustment with a life-threatening disease, fear of stigma
and discrimination, and CNS invasion of the virus as well as adverse
eﬀects of anti-retroviral (ARV) medications may all contribute to es-
tablishment of a psychiatric disorder [15,18].
Although there is a bi-directional correlation between mental dis-
orders and HIV infection, this reciprocity goes beyond. Psychiatric
disorders can aﬀect the disease's course, clinical outcome and pro-
gression towards AIDS through disturbances in immune system mod-
ulation, poorer access to treatment and care, and lack of optimal
treatment adherence [19–22].
There is scarcity of knowledge regarding mental health problems
and service utilization of PLWHA in Iran. Moreover, literature in this
regard lacks implementation of structured diagnostic tools. In this
study, we examined prevalence, severity and correlated factors of
psychiatric disorders in the past 12months, as well as the pattern of
health service utilization for mental disorders in a group of HIV patients
in a main referral center for HIV treatment and care in Tehran, Iran.
2. Methods
This is a cross-sectional study on 250 randomly selected HIV+ pa-
tients from the referral center for HIV treatment and care in Tehran,
Iran. The study was approved by the Ethics Committee of Tehran
University of Medical Sciences in Iran.
2.1. Field work and sampling
Participants who were 15–64 years of age, able to communicate in
Persian language, physically and cognitively competent to complete the
interview and whose HIV infection had been diagnosed at least four
weeks prior to the interview were eligible for this study.
The study was conducted at the Imam Khomeini Hospital's HIV
treatment and care center, from mid-2012 to early 2013. The center
provides HIV counseling and testing as well as HIV treatment and care
services (free of charge anti-retroviral treatment, CD4 count and viral
load assessment). Systematic random sampling was applied for se-
lecting the eligible participants. During the ﬁeld work on each day, the
ﬁrst case was selected using a random number from the list of the re-
ferring clients and subsequent cases were recruited using a ﬁxed in-
terval. On each working day, an average number of three interviews
were carried out from the center's 25 daily referrals. Those who refused
to cooperate were substituted by cases matched by their gender and
anti-retroviral regimen, whether receiving ART or not, on the same day.
Participation in the study was voluntary and informed consent was
obtained for the interview. Patients would not face any limitation in
receiving services if they rejected participation in the study.
Participants were welcomed with refreshments and a snack. Referral to
free of charge mental health services, located at the same center, was
provided upon request but no monetary incentive was given. All in-
terviews took place in a private setting. All questionnaires and data-
bases were kept conﬁdential.
Interviewers consisted of three clinical psychologists, having prior
experience in working with psychiatric patients and implementing si-
milar questionnaires. They received intensive training during the pre-
liminary phases of the survey about ethical issues, interview, process of
sampling and ﬁeld work. A quality control protocol was implemented in
diﬀerent stages of ﬁeld work and data management. Participation rate
was 93%.
2.2. Measures and instruments
We used a package of instruments which was adapted from the
comprehensive battery used in the Iranian National Mental Health
Survey (IranMHS) [23]. The paper and pencil version of questionnaires
were ﬁlled out by interviewers through face-to-face interviews. The
questionnaires used in this paper are as follows:
Composite International Diagnostic Interview (CIDI v2.1) was used
to assess the prevalence of mental disorders over the past 12months.
The validity of the Persian version of CIDI has been previously eval-
uated [24]. The included diagnoses consisted of depressive disorders,
bipolar disorders, panic with or without agoraphobia, agoraphobia,
social phobia, generalized anxiety, obsessive-compulsive and post-
traumatic stress disorder, and drug and alcohol use disorders. Illicit
drugs included opioids, cannabis, stimulants, hallucinogens and in-
halants. Bipolar disorders were assessed using the lifetime version of
the instrument and others were evaluated using the past 12-month
version. Somatoform disorders were assessed using a World Health
Organization screening instrument recommended for primary care
settings. Moreover, questions about suicidal ideation and attempts, and
aggressive behavior were also included. History of perpetrating phy-
sical aggression in the past 12months, including destruction of prop-
erties, physical violence towards family members or others were asked
through four questions. Serious aggressive behavior was deﬁned by
either requiring medical treatment of the victim or leading to legal
consequences.
Sheehan Disability Scale (SDS) was used to assess the degree of
disability associated with the psychiatric disorders, in four domains of
work performance, household responsibilities, social life and intimate
interpersonal relationship. Psychometric properties of SDS have been
assessed and have showed good reliability and validity indices [25]. We
assessed the severity of psychiatric disorders based on the following
deﬁnitions:
• Serious mental disorders consisted of either bipolar I disorder,
physiological dependence to a substance; OR diagnosis of a mental
disorder with severe impairment in two or more domains of func-
tioning based on SDS; OR a suicidal attempt in the last 12months in
the presence of any psychiatric disorder;
• Moderate mental disorders were deﬁned as a presence of a mental
disorder with moderate impairment in at least two domains of SDS,
or substance dependence without physiological dependence, and
lack of criteria for serious mental disorders;
• Mild disorders were those which were neither serious nor moderate.
We assessed health and non-health service utilization for mental
health problems by using a questionnaire previously developed and
adopted in IranMHS. Health service utilization was deﬁned as having
accessed any healthcare provider including mental health professionals
and general practitioners in the past 12 months. It consisted of hospi-
talization, outpatient service use, hotline and telephone counseling
services, referring to pharmacist for reﬁlling a physician's prescription
and drug harm reduction services. Non-health services included alter-
native medicine (e.g. herbal medicine, acupuncture and pray-writers),
attending self-help groups and direct referral to pharmacist without
prescription. Minimally adequate treatment (MAT) for mental health
services was derived from the deﬁnition used in World Mental Health
Survey [26], as either having made at least two visits in the last twelve
months, or having made a visit to the health-care system for a mental
health issue in the past month.
Data on demographic characteristics, perceived social support and
socio-economic status were also gathered. Regarding socio-economic
status, participants were classiﬁed as high, moderate and low in equal
proportions according to their household's speciﬁcations and assets
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(based on an instrument used in a national health services utilization
study [27]). The Multidimensional Scale of Perceived Social Support
(MSPSS) was used to measure perceived social support and MSPSS has
been validated in Persian language [28]. It consists of 12 seven-point
Likert scale questions that assesses the participant's perception of social
support from family, friends, and signiﬁcant others [29]. As re-
commended, any mean scale score ranging from 1 to 2.9 was con-
sidered as low support, a score of 3 to 5 as moderate support, and a
score from 5.1 to 7 as high support.
2.3. Statistical analysis
PASW 18 (SPSS Inc., Chicago, IL, 2010) and STATA (12.0 SE)
software were used for statistical analysis. In addition to descriptive
analyses (prevalence and 95% conﬁdence intervals for psychiatric dis-
orders and other mental conditions), bivariate and multivariate ana-
lyses were also conducted for determining correlates of any psychiatric
disorder in the past 12months. These included socio-demographic
characteristics and HIV-speciﬁc variables (i.e. CD4 count, HIV dis-
closure status and social support) which were also assessed in other
studies. t-Tests and chi-squared tests were used in bivariate model and
logistic regression in the multivariate models. All variables showing
signiﬁcant correlations with the outcomes (P≤ .2 level of signiﬁcance)
in bivariate analysis were entered into a multivariate logistic regression
model.
3. Results
From the total 250 participants 147 (59%) were male. The mean age
of participants was 35.9 (± 8.9) with a range of 16–61. Among the
participants, 110 (44.0%) were head of their household. Regarding
marital status, 179 (71.6%) were either married or previously married
and 113 (63.1%) had at least one child. Regarding education, 15.1%
had primary education, 71.7% had high school education or more. A
total of 131 (52.2%) participants were employed at the time of the
interview, but only 80 (32.0%) were employed throughout the whole
past 12months. The average length of employment was 8.9 (± 4.0)
months. The average length from the time HIV diagnosis was reported
to be 6.1 (± 4.0) years. From the respondents, 192 (76.8%) were re-
commended to receive HAART medications and 184 (73.6%) were on
treatment at the time of the study.
Table 1 describes prevalence of psychiatric disorders among parti-
cipants. As shown in the table, 50.2% had at least one psychiatric dis-
order in the past 12 months, 52 (21.1%) had a single disorder, 39
(15.8%) had two disorders and 33 (13.4%) were found to have more
than two psychiatric disorders. Serious disorders were quite prevalent,
aﬀecting 77.4% of those with a psychiatric diagnosis (38.2% of total
respondents) and signiﬁcantly higher in men. This pattern was observed
across all psychiatric disorders.
Mood disorders were the most prevalent psychiatric comorbidity
followed by anxiety disorders. The most prevalent psychiatric diagnosis
was major depressive disorder, aﬀecting 32.1% of participants.
Generalized anxiety disorder was seen in 13.7% of the respondents.
Suicidal thoughts and attempts were commonly reported. One out of
ﬁve reported having suicidal thoughts and 7% reported having an at-
tempt in the past 12months. Physical aggression was reported by
42.2% and serious aggressive behavior was mentioned by 7.8% of the
respondents.
Participants were asked to identify their main substance of use in
the past 12months. Opioids were the most common and reported by
9.2% of participants followed by alcohol, amphetamine type stimulants
and cannabis (6.8%, 5.6% and 1.2% respectively). Prevalence of sub-
stance use disorders (according to DSM-IV) based on CIDI was 17.1%
(Table 2). No cases of hallucinogen and inhalant use disorders were
found in this study. Intravenous drug use in the past 12months and last
month was mentioned by 5.6% and 2.4% of the participants,
respectively.
In bivariate analysis, psychiatric disorders were more prevalent in
men, those who were single (compared to married participants), un-
employed and among those who had lower social support. Multivariate
logistic regression analysis was used in order to assess possible con-
founding factors associated with mental health problems. As shown in
Table 3, the only signiﬁcant factor was lower social support.
Perceived need and health service utilization for mental problems
are summarized in Table 4 and Fig. 1. Totally, 154 (62.3%) mentioned
that they felt the need to seek help for mental problems in the past
12months and 69 (27.5%) of the total sample were eventually referred
for treatment.
From 122 patients with any psychiatric disorder, 98 (80.3%) per-
ceived the need to seek professional help in the past 12months.
However, 51 (41.1%) received a health service for mental problems
resulting in a total of 58.9% unmet mental health need. Unmet need did
not signiﬁcantly diﬀer across age, gender, socio-economic status, per-
ceived social support, CD4 count and diﬀerent categories of psychiatric
disorders. Although, those with a serious psychiatric disorder reported
higher perceived need and health service utilization, the rates were not
signiﬁcantly diﬀerent when comparing the severity of the disorders. In
those with a psychiatric diagnosis who had received health services for
their mental health problems in the past 12months (n=51), only 27
(53.0%) had received minimally adequate treatment, i.e. 22.1% of the
total sample with any psychiatric disorder. The rates of minimally
adequate treatment did not diﬀer signiﬁcantly across diagnostic cate-
gories and severity (Table 4).
Table 5 demonstrates speciﬁc types of health and non-health ser-
vices used in the past 12months. Non-health services were more fre-
quently utilized than health services in the past 12months and mainly
consisted of self-help groups, directly referring to the pharmacy for
prescription and alternative medicine.
In those who perceived the need to seek help for mental problems
but had not utilized any service, we inquired about the reasons for
refusal to seek treatment. The most common answers were considering
the mental problem as either untreatable or transient, mentioned by
66.7% and 62.2%, respectively. Fear of discrimination and HIV-asso-
ciated stigma was mentioned by 55% as the reason for refusal.
Treatment for mental problems was believed to be unavailable or in-
accessible by 24.7%.
4. Discussion
This study is among the very few and the ﬁrst in Iran which im-
plemented a structured diagnostic tool in order to assess the prevalence
of mental disorders in PLWHA. A high prevalence of psychiatric dis-
orders was found in this study. Just more than half had a history of any
psychiatric disorder in the past 12months, which according to the latest
national mental health survey (IranMHS), is more than double the
corresponding rate in adult general population (23.6%) [30]. Freeman
and colleagues found an overall prevalence of 43.7 of psychiatric dis-
order among PLWHA using a similar method [31]. High rates of psy-
chiatric disorders were also reported in two other studies implementing
the CIDI instrument [32,33]. Compared with general population [30],
mood disorders (especially major depressive disorder) and anxiety
disorders (especially generalized anxiety disorder and post-traumatic
stress disorder) were more than two times more prevalent than the
general population. Again, compared with general population [34],
suicidal ideation and attempt in the past 12months were 3.4 and 5.2
times more prevalent, respectively. Physical aggression and serious
aggressive behavior were also much higher than the general population
(1.3 and 4.5 times higher, respectively).
In addition to few studies which have used a structured diagnostic
tool to assess mental disorders, elevated rates of psychiatric disorders
among PLWHA were reported in other studies using screening tools
[16,35,36]. Bing et al. in a nationally representative sample of PLWHA
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in the United states found that nearly half screened positive for a mental
problem [37]. Other studies have also found high rates of psychiatric
disorders among PLWHA [17,38,39]. In an Iranian study on a sample of
PLWHA, almost all participants had a mental illness based on a
screening instrument [40].
Psychiatric disorders were independently associated with perceived
social support. The role of perceived social support on the mental well-
being of PLWHA has been demonstrated in other studies as well
[41,42]. However, age, gender, level of education, marital status, em-
ployment, HIV disclosure and CD4 count did not seem to have an in-
dependent eﬀect. Among the mentioned variables, CD4 count also
seems to be of great clinical signiﬁcance and is somehow considered as
an illness deﬁning factor. Some studies have proposed correlation of
mental disorder with CD4 counts especially CD4 < 200 [43,44].
Whereas other studies have failed to show a correlation between CD4
count and mental health disorders [45].
In this study, psychiatric disorders were more frequently found in
men (Crude OR=1.92, 95% CI: 1.15–3.26). This is in contrast with the
ﬁndings from the national survey (IranMHS) which found them to be
more prevalent in women [30]. Some other studies have also proposed
that in chronic conditions such as cancers, the rates of psychiatric
disorders might not be signiﬁcantly diﬀerent in the two sexes [46].
As mentioned earlier, most of those with any psychiatric disorder
(77.4%) suﬀered from a serious mental illness. The ﬁndings of the
current study can be compared to the ﬁndings of the national Mental
Health Survey (IranMHS) in which almost one-thirds (34.3%) of in-
dividuals with a mental disorder had a serious illness [30]. The ob-
served numbers indicate that psychiatric disorders are not only more
prevalent, but also more severe. The greater severity of psychiatric
disorders among PLWHA further emphasizes on the need of provision of
more intensive mental health services.
Again, compared with general population, the prevalence of
Table 1
Prevalence of psychiatric disordersand conditions in the past 12months.
Total Female Male
Number (%) 95% CIa Number (%) 95% CI Number (%) 95% CI
Any psychiatric disorderb 124 (50.2) 43.8–56.6 41 (40.6) 31.0–51.0 83 (56.8) 48.4–65.0
Mild 8 (3.2) 1.0–5.4 3 (2.9) 0–6.1 5 (3.4) 0.5–6.4
Moderate 20 (8.0) 4.6–11.4 8 (7.7) 2.5–12.9 12 (8.2) 3.7–12.7
Severe 96 (38.4) 32.3–44.5 30 (28.8) 66 (45.2) 37.1–53.3
Any anxiety disorder 77 (30.7) 24.9–36.4 27 (26.0) 17.5–34.5 50 (34.0) 26.3–41.7
Panic with or without agoraphobia 15 (6.0) 3.0–9.0 4 (3.8) 0.1–7.6 11 (7.6) 3.2–11.9
Agoraphobia without panic 3 (1.2) 0.0–2.6 2 (1.9) 0.0–4.6 1 (0.7) 0.0–2.0
Social phobia 11 (4.4) 1.8–6.9 4 (3.8) 0.1–7.6 7(4.8) 1.3–8.2
Generalized anxiety disorder 34 (13.6) 9.3–18.9 9 (8.7) 3.2–14.1 25 (17.1) 11.0–23.3
Obsessive-compulsive disorder 26 (10.4) 6.6–14.2 10 (9.6) 3.9–15.3 16 (10.9) 5.8–16.0
Post-traumatic stress disorder 22 (8.8) 5.2–12.3 9 (8.7) 3.2–14.1 13 (8.8) 4.2–13.5
Any mood disorder 86 (34.5) 28.6–40.5 32 (30.8) 21.8–39.7 54 (37.2) 29.3–45.2
Any depressive disorder 80 (32.1) 26.3–38.0 30 (28.8) 20.1–37.6 50 (34.5) 26.7–42.3
Major depressive disorder 80 (32.1) 26.3–38.0 30 (28.8) 20.1–37.6 50 (34.5) 26.7–42.3
Dysthymia 1 (0.4) 0.0–1.2 0 (0) 0 1 (0.7) 0.0–2.0
Bipolar I disorder 6 (2.4) 0.5–4.3 2 (1.0) 0.0–2.9 4 (3.4) 0.4–6.4
Any alcohol/drug use disorder 43 (17.1) 12.4–21.8 10 (9.6) 3.9–15.3 33 (22.4) 15.6–29.2
Any alcohol use disorder 10 (4.0) 1.5–6.4 3 (2.9) 0.0–6.1 7 (4.8) 1.3–8.2
Alcohol dependence 8 (3.2) 1.0–5.4 2 (1.9) 0.0–4.6 6 (4.1) 0.9–7.3
Alcohol abuse 2 (0.8) 0.0–1.9 1 (1.0) 0.0–2.9 1 (0.7) 0.0–2.0
Any drug use disorder 35 (13.9) 9.6–18.3 7 (6.7) 1.9–11.6 28 (19.0) 12.6–25.4
Any drug dependence 30 (12.0) 7.9–16.0 5 (4.8) 0.7–9.0 25 (17.0) 10.9–23.1
Any drug abuse 6 (2.4) 0.5–4.3 2 (1.9) 0.0–4.6 4 (2.7) 0.07–5.4
Suicidal thought 53 (21.3) 16.2–26.4 21 (20.4) 12.5–28.2 32 (21.9) 15.2–28.7
Suicidal attempt 17 (6.8) 3.7–10.0 7 (6.8) 1.9–11.7 10 (6.8) 2.7–11.0
Physical aggression 105 (42.2) 36.0–48.3 37 (35.9) 26.6–45.3 68 (46.6) 38.4–54.7
Serious physical aggression 19 (7.8) 4.4–11.2 2 (2.0) 0.0–4.8 17 (11.8) 6.5–17.1
Any somatoform disorderc 13 (5.2) 2.4–8.0 8 (7.7) 2.5–12.9 5 (3.4) 0.5–6.4
a CI= Conﬁdence Interval.
b Psychiatric disorders consist of anxiety, mood or alcohol/substance use disorders.
c Not included in the deﬁnition of “any psychiatric disorder”.
Table 2
Prevalence of substance use and use disorders (according to DSM-IV-TR) based on CIDI (N=250).
Type of substance ≥ 5 times substance use in the past
12months
substance abuse in the past
12months
substance dependence in the past
12months
substance use disorders in the past
12months (DSM-IV)
Number (%) 95% CIa Number (%) 95% CI Number (%) 95% CI Number (%) 95% CI
Opioids 31 (12.4) 8.3–16.5 1 (0.4) 0.0–1.2 23 (9.2) 5.6–12.8 24 (9.6) 5.9–13.2
Cannabis 6 (2.4) 0.5–4.3 1 (0.4) 0.0–1.2 2 (0.8) 0.0–1.9 3 (1.2) 0.0–2.5
Stimulantsb 24 (9.4) 5.9–13.3 5 (2.0) 0.3–3.7 19 (7.6) 4.3–10.9 24 (9.4) 5.9–13.3
Any illicit drug
without alcohol
44 (17.6) 12.8–22.4 6 (2.4) 0.5–4.3 30 (12.7) 7.9–16.0 35 (14.0) 9.7–18.3
Alcohol 24 (9.6) 5.9–13.3 2 (0.8) 0.0–1.9 8 (3.2) 1.0–5.4 10 (4.0) 1.5–6.4
Any substance 67 (26.8) 21.3–32.3 8 (3.2) 1.0–5.4 36 (14.3) 10.0–18.7 43 (17.1) 12.4–21.8
a CI= Conﬁdence Interval.
b Stimulants=Amphetamine-type stimulants and cocaine.
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substance use disorders was found to be higher in this study. Opioids
were main drug of use which is similar to the country's drug use scene.
Almost all patterns of illicit drug and alcohol use in the past 12months
including> 5 times use, substance abuse and substance dependence
were found to be more than four times higher among PLWHA than the
general population [47,48]. Substance use disorder in PLWHA has been
the focus of attention for its possible role in treatment adherence and
thus the outcome of the infection [21,49]. Regardless of the impact of
substance use disorders on adherence, the authors believe that the high
rates of substance use disorders and injecting drug use in the study
population should herald the need to give speciﬁc attention to drug
treatment and harm reduction services in the treatment and care of
PLWHA.
Another intriguing ﬁnding of this study was low rate of health
service utilization for mental problems. Among those who were diag-
nosed with any psychiatric disorder in the past 12months, almost 41%
had utilized a health service in the same period and only 22% had re-
ceived minimally adequate treatment. Mental health service utilization
has been reported to be relatively low in other studies, as well [32,50]
[32]. We also found high rates of non-health service utilization for
mental disorders (64.5%) (mainly referring to pharmacy and self-help
group) which is much higher than the similar rate in those with a
psychiatric disorder in general population (38.4%) [34]. This might be
partially justiﬁed by high rates of substance use disorders among
Table 3
Regression analysis of factors associated with mental disorders in the past 12months.
Variables Any psychiatric disorder in the past 12months
Number (%) Crude odds ratio (95% CIa) P value Adjusted odds ratio (95%CI) P value
Sex
Female (n=101) 41 (40.6) 1 0.012 1 0.12
Male (n=146) 83 (56.8) 1.93 (1.15–3.23) 1.64 (0.87–3.09)
Age
15–29 (n=59) 26 (44.1) 1 0.51
30–49 (n=167) 87 (52.7) 1.41 (0.78–2.57) – –
50–64 (n=21) 10 (47.6) 1.51 (0.43–3.13)
Marital status
Married (n= 122) 51 (41.8) 1 0.026 1
Single (n=72) 44 (61.1) 2.18 (1.21–3.97) 1.22 (0.61–2.45) 0.57
Previously married (n=53) 29 (54.7) 1.68 (0.88–3.22) 1.18 (0.57–2.45) 0.65
Education
High school and higher education (n=180) 82 (46.6) 1 1
Middle school and lower education (n=71) 42 (59.2) 1.66 (0.95–2.90) 0.07 1.61 (0.88–2.95) 0.13
Employment
Employed (n=205) 93 (45.4) 1 0.001 1 0.053
Unemployed (n=42) 31 (73.8) 3.39 (1.62–7.12) 2.23 (0.99–5.01)
Socio-economic status
Low (n=65) 32 (49.2) 1 0.51
Middle (n=83) 43 (51.8) 1.11 (0.58–2.12) – –
High (n=77) 33 (42.9) 0.77 (0.40–1.50)
Disclosure
No (n= 25) 14 (56.0) 1 0.54 – –
Yes (n=222) 110 (49.5) 0.77 (0.34–1.77)
CD4
<200 (n=63) 31 (49.2) 1 0.77 – –
200–350 (n=57) 32 (56.1) 1.32 (0.64–2.71)
351–500 (n= 59) 29 (49.2) 0.99 (0.49–2.03)
>500 (n=62) 29 (46.8) 0.91 (0.45–1.83)
Perceived social support
High (n=84) 33 (39.3) 1 0.001 1
Moderate (n=129) 68 (52.7) 1.72 (0.99–3.01) 1.64 (0.92–1.94) 0.09
Low (n=26) 21 (80.8) 6.49 (2.23–18.91) 6.15 (1.98–19.05) 0.002
The numbers in bold type show statistically signiﬁcant results.
a CI= Conﬁdence Interval.
Table 4
Demand and service utilization across diﬀerent psychiatric diagnoses and severity of disorders.
Psychiatric Disorder Perceived need to seek professional help for
mental health in the past 12months
Any health service utilization for mental
health in the past 12months
Receiving minimally adequate treatment for
mental disorders
Number (%) 95% CIa Number (%) 95% CI Number (%) 95% CI
Total (N=247) 154 (62.3) 56.3–68.4 69 (27.5) 21.9–33.1 30 (12.1) 8.0–16.2
Any psychiatric disorder
(n=122)
98 (80.3) 73.2–87.4 51 (41.1) 32.4–49.9 27 (22.1) 14.7–29.6
Mood disorders (n=84) 75 (89.3) 82.6–96.0 38 (44.2) 33.6–54.8 20 (23.8) 14.6–33.0
Anxiety disorders (n=75) 63 (84.0) 75.6–92.4 36 (46.8) 35.5–58.0 22 (29.3) 18.9–39.8
Alcohol/substance use
disorders (n=43)
38 (88.4) 78.6–98.1 18 (41.9) 26.9–56.9 8 (18.6) 6.8–30.4
Mild disorder (n= 7) 6 (85.7) 57.6–100 3 (37.5) 1.5–73.5 1 (14.3) 0–42.6
Moderate disorder (n= 20) 13 (65.0) 43.4–86.6 5 (25.0) 5.4–44.6 2 (10.0) 0–23.6
Serious disorder (n=95) 79 (83.2) 75.6–90.7 43 (44.8) 34.6–54.8 24 (25.3) 16.4–34.1
a CI= Conﬁdence Interval.
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PLWHA. The authors would like to emphasize that the observed low
rate of health service utilization for a mental problem was among the
active clients of a referral HIV treatment and care center. This high-
lights the need for improvement of mental health treatment and care for
PLWHA. Several strategies can be used to improve mental health care
for PLWHA. Using self-rated screening tests, training of the health care
staﬀ who are working with the PLWHA on identiﬁcation of mental
health problems, setting up responsive referral infrastructure and in-
tegration of mental health services into treatment and care of PLWHA.
Similar HIV treatment and care which is free of charge, mental health
care should be provided in a free or aﬀordable manner. Since social
support was a signiﬁcant factor correlated to mental health, promotion
of self-help groups and providing social services might promote mental
health status among PLWHA. The so-called “Positive Clubs” in the
country have set good examples of self-help groups, trying to empower
the clients and provide a range of supportive social services for PLWHA
and their partners [51].
Participants were mostly 30–39 years of age, married, employed and
had high school education. Regarding the gender distribution, women
consisted 41% of the sample. According to the latest national report in
2017, the male/female ratio among registered cases of HIV is 5.4. The
same report states a rapid increase of HIV incidence among women
since 2007 [4]. Women might consist up to one third of the total esti-
mated new cases of HIV infection. Authors believe that higher than
expected rates of female participants in the study might be due to
higher HIV service utilization among women.
The study beneﬁted from implementing a structured diagnostic tool
to assess prevalence of psychiatric disorders among participants. The
study achieved a high participation rate. It might be due to the fact that
the interviewers were clinical psychologists and were able to establish
good rapport with the clients. The clients also had to spend quite some
time at the VCT center, waiting for their HIV treatment and care ap-
pointments. This might have also raised their participation in the study.
This was a cross-sectional study and was not able to reveal causal
relationship between HIV and psychiatric disorders. In addition, we
selected several common mental disorders for assessment in this study
(mood, anxiety and substance related disorders) and were not able to
assess psychotic disorders, simple phobias and some other disorders.
Moreover, including participants from active clients of an HIV treat-
ment and care center without reaching out to other patients could be
considered as another study limitation. Although the center was an
academic referral one, generalizing the ﬁndings should be done with
caution.
Considering the long-term and the chronic nature of HIV infection
and the associated psychiatric disorders, future longitudinal studies
could shed more light on how service delivery might inﬂuence the
course of the disease and provide more detailed picture of diﬀerent
domains of functioning.
5. Conclusions
In conclusion, we found a high rate of psychiatric disorders among
PLWHA, the majority of whom were suﬀering from a serious mental
illness. Despite these ﬁndings, health service utilization and receiving
minimally adequate treatment for mental health problems remain
drastically suboptimal. Based on the observed discrepancy between
mental health need and service utilization, authors would like to em-
phasize that mental health services should be promoted in the country.
The ﬁndings of this study can also have implications in better treatment
and care of PLWHA.
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Table 5
Service utilization for mental problems in the past 12months.
Total sample (n=250) Any psychiatric disorder (n=122)
Number (%) 95% CIa Number (%) 95% CI
Any perceived need to use health care services 154 (62.3) 56.3–68.4 98 (80.3) 73.2–87.4
Any health and non-health service use 145 (74.4) 68.2–80.5 91 (79.1) 71.6–86.6
Health service use 69 (27.5) 21.9–33.1 51 (41.1) 32.4–49.9
Outpatient treatment 45 (17.9) 13.2–22.7 36 (29.0) 21.0–37.1
Drug treatment center 7 (2.8) 0.7–4.8 7 (5.6) 1.5–9.7
Other health centers 38 (15.1) 10.7–19.6 29 (23.4) 15.9–30.9
Pharmacy for reﬁlling physicians' prescriptions 24 (9.8) 6.0–13.5 18 (14.8) 8.4–21.1
Hospital admission 5 (2.0) 0.3–3.7 5 (4.0) 0.5–7.5
DICsb 11 (5.6) 2.3–8.8 10 (8.8) 3.5–14.0
Non-health service use in L12M 131 (52.2) 46.0–58.4 80 (64.5) 56.0–73.0
Self-help group 55 (27.8) 21.5–34.1 38 (33.3) 24.6–42.1
Pharmacy for prescription of medicationc 62 (25.2) 19.7–30.7 42 (34.4) 25.9–42.9
Residential drug services (camps)d 1 (0.4) 0.0–1.2 1 (0.8) 0.0–2.4
Alternative medicine 52 (20.8) 15.7–25.9 29 (23.6) 16.0–31.1
a CI: Conﬁdence interval.
b DICs: Drop-In Centers.
c In Iran, pharmacists are not allowed to prescribe medications. Therefore, it is classiﬁed as a non-health service.
d These residential services are run by self-help groups.
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